UCSF researchers have discovered that a key cellular defect that disturbs the production of proteins in human cells can lead to cancer susceptibility. The scientists also found that a new generation of inhibitory drugs offers promise in correcting this defect. According to the study team, this discovery has broad clinical implications in the fight against cancer and could affect treatment of lymphoma and many other forms of the disease, including prostate cancer, breast cancer, colorectal cancer, brain cancer and multiple myeloma.
The findings are featured as the cover story in the March 16, 2010 issue of the scientific journal Cancer Cell. The discovery was made in the laboratory of UCSF faculty scientist Davide Ruggero, PhD, whose lab team is doing research in the burgeoning field of study on how defects in protein synthesis can lead to cancer susceptibility.
The research was funded by the National Institutes of Health.
Ruggero is a Leukemia & Lymphoma Society Scholar.
No comments:
Post a Comment